Investigators: Most data on drugs never available

“Regardless of the cause, publication bias harms the public good by impairing
the ability of clinicians and patients to make informed clinical decisions, and
the ability of scientists to design safer and more efficient trials based on
past findings,” the authors wrote. “Publication bias can thus be considered a
form of scientific misconduct.” …

Continue reading

Atypicals no better than older meds in kids

That’s bad news for the companies that make leading atypicals–Johnson & Johnson Risperdal, Eli Lilly (Zyprexa), Bristol-Myers Squibb (Abilify),Pfizer (Geodon), AstraZeneca(Seroquel). Prescription rates for these meds have enjoyed a
strong growth curve, increasing more than fivefold among children over the past
15 years. …

Continue reading